Search Within

Melanoma Disease Management Team

Formats
  1. Journal Article (1604)
  2. Meeting Abstract (791)
  3. Book Section (104)
  4. Review (72)
  5. Editorial (58)
  6. Research Letter (45)
  7. Guidelines (26)
  8. Conference Paper (22)
  9. Correspondence (21)
  10. Miscellaneous (16)
  11. Book Whole (11)
Groups
  1. Department of Medicine (1690)
  2. Survivorship Research (1193)
  3. Solid Tumor Oncology Division (1052)
  4. Department of Pathology and Laboratory Medicine (957)
  5. Surgery (947)
  6. Melanoma and Immunotherapeutics Service (793)

More Groups

People
  1. Klaus Busam (698)
  2. Daniel Coit (543)
  3. Allan Halpern (401)
  4. Michael Postow (369)
  5. Alexander Shoushtari (247)
  6. Jedd Wolchok (222)

More People

Years
  1. 2025 (89)
  2. 2024 (138)
  3. 2023 (160)
  4. 2022 (167)
  5. 2021 (149)
  6. 2020 (142)

More Years

Publications
  1. Journal of Clinical Oncology (269)
  2. Annals of Surgical Oncology (221)
  3. Journal of the American Academy of Dermatology (123)
  4. Journal of Investigative Dermatology (84)
  5. Modern Pathology (67)
  6. American Journal of Surgical Pathology (64)

More Publications

Publishers
  1. Springer (341)
  2. American Society of Clinical Oncology (284)
  3. Elsevier Inc. (231)
  4. Lippincott Williams & Wilkins (229)
  5. Wiley Blackwell (162)
  6. Elsevier Science, Inc. (160)

More Publishers

Results (2770)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • 1(8)F-FDG PET/CT for post-treatment surveillance imaging of patients with stage III Merkel cell carcinoma
    Journal Article

    Mahajan, S.; Barker, C. A.; Mauguen, A.; D’Angelo, S. P.; Yeh, R.; Pandit-Taskar, N.
    Journal of Nuclear Medicine (2022)

    Fulltext@MSK | Save
  • Checkpoint inhibition induced pruritus during cancer therapy is associated with skin IL-31 and CCL22 expression
    Meeting Abstract

    Wang, E.; Lyubchenko, T.; Goleva, E.; Kraehenbuehl, L.; Ketosugbo, K.; Moy, A.; Hellmann, M.; Kern, J.; Lacouture, M.; Leung, D.
    Journal of Allergy and Clinical Immunology (2022)

    Fulltext@MSK | Save
  • Disease progression and trends in the management of in transit melanoma
    Meeting Abstract

    Rhodin, K. E.; Bello, D.; Farrow, N.; Mosca, P.; Salama, A. K.; Nair, S.; Tyler, D.; Ariyan, C.; Beasley, G.
    Annals of Surgical Oncology (2022)

    Fulltext@MSK | Save
  • In-transit melanoma: A multi-institutional analysis of outcomes
    Meeting Abstract

    Bello, D.; Rhodin, K. E.; Brady, M. S.; Bartlett, E.; Mosca, P.; Salama, A. K.; Tyler, D.; Ariyan, C.; Beasley, G.
    Annals of Surgical Oncology (2022)

    Fulltext@MSK | Save
  • Sentinel lymph node biopsy in patients with t1a cutaneous malignant melanoma
    Meeting Abstract

    Shannon, A. B.; Carr, M.; Bogatch, K.; Thaler, A. S.; Kelly, N. J.; Fowler, G.; Straker, R. J.; Sondak, V.; Miura, J. T.; Faries, M. B.; more...
    Annals of Surgical Oncology (2022)

    Fulltext@MSK | Save
  • Stage migration as a consequence of omitting completion lymph node dissection for melanoma
    Meeting Abstract

    Senders, Z. J.; Bartlett, E.; Mouw, T. J.; McMasters, K. M.; Egger, M. E.
    Annals of Surgical Oncology (2022)

    Fulltext@MSK | Save
  • T-VEC treatment reverses PD-1 resistance by altering the microenvironment of tumors
    Meeting Abstract

    Theriot, J.; Hu, J.; Wong, R. J.; Wolchok, J.; Rudensky, A.; Ariyan, C.
    Annals of Surgical Oncology (2022)

    Fulltext@MSK | Save
  • Proton pump inhibitor use and efficacy of nivolumab and ipilimumab in advanced melanoma
    Journal Article

    Homicsko, K.; Dummer, R.; Hoeller, C.; Wolchok, J. D.; Hodi, F. S.; Larkin, J.; Ascierto, P. A.; Atkinson, V.; Robert, C.; Postow, M. A.; more...
    Cancers (2022)

    Fulltext@MSK | Save
  • Refractive shifts and changes in corneal curvature associated with antibody-drug conjugates
    Journal Article

    Canestraro, J.; Hultcrantz, M.; Modi, S.; Hamlin, P. A.; Shoushtari, A. N.; Konner, J. A.; Tew, W. P.; Iyengar, N. M.; Heinemann, M.; Abramson, D. H.; more...
    Cornea (2022)

    Fulltext@MSK | Save
  • A diagnostic dilemma: Atypical melanocytic lesions arising in the setting of treatment with the BRAF inhibitor, vemurafenib
    Journal Article

    Clark, M.; Imbriano, P.; Harwood, M.; Busam, K.; Robinson-Bostom, L.
    JAAD Case Reports (2022)

    Fulltext@MSK | Save